Get started
Author

Hans Bentzen

Observed names: Bentzen, H, Bentzen, H., Bentzen, Hans, Bentzen, Hans Herluf, Bentzen, Hans Herluf Nørgaard, Bentzen, Hans Herluf Nørregaard, H. BENTZEN, H. Bentzen, H. H. Bentzen, H. H. N. Bentzen, H. Herluf Bentzen, H.E.N. Bentzen, Hans BENTZEN, Hans H. Bentzen, Hans H. N. Bentzen, Hans Herluf Bentzen, Hans Herluf Nørregaard Bentzen
OpenAlex ID: A5110008631
Nordic MCL 2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem‐cell support: still very long survival but late relapses do occur
2012 · Christian H. Geisler, Arne Kolstad, et al. · British Journal of Haematology · 272
15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial ( MCL 2): prolonged remissions without survival plateau
2016 · Christian W. Eskelund, Arne Kolstad, et al. · British Journal of Haematology · 217
PDF
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma
2014 · Arne Kolstad, Anna Laurell, et al. · Blood · 106
Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans
2001 · R. S. Pedersen, H. Bentzen, et al. · American Journal of Physiology-Renal Physiology · 91
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years
2016 · Arne Kolstad, Lone Bredo Pedersen, et al. · Transplantation and Cellular Therapy · 64
PDF
Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load
2003 · Robert S. Pedersen, H. Bentzen, et al. · Kidney International · 50
A population‐based study of prognosis in advanced stage follicular lymphoma managed by watch and wait
2015 · Tarec Christoffer El‐Galaly, Anders E. Bilgrau, et al. · British Journal of Haematology · 39
Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1
2024 · Alexey Danilov, Bita Fakhri, et al. · Blood · 34
PDF
Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3
2020 · Christian Winther Eskelund, Kostas Dimopoulos, et al. · HemaSphere · 34
Richter’s transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study
2020 · Yasmin Ben-Dali, Mariam H. Hleuhel, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 34
The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor
2018 · Maja D. Andersen, Peter Kamper, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 34
Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure
2004 · Hans Bentzen, Robert S Pedersen, et al. · International Journal of Cardiology · 33
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial
2025 · David J Lewis, David J Lewis, et al. · The Lancet · 26
Subcutaneous Epcoritamab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Preliminary Results from the Epcore CLL-1 Trial
2021 · Arnon P. Kater, Jacob Haaber Christensen, et al. · Blood · 22
Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort
2020 · Charlotte Madsen, Trine Lindhardt Plesner, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 19
A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma
2012 · Kristiane Hornung Hamborg, Hans Herluf Nørregaard Bentzen, et al. · European Journal Of Haematology · 19
PDF
Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure
2003 · Hans BENTZEN, Robert S. PEDERSEN, et al. · Clinical Science · 18
Influence of training habits on exercise-induced changes in plasma atrial and brain natriuretic peptide and urinary excretion of aquaporin-2 in healthy man
2002 · H. Bentzen, R. S. Pedersen, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 14
Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study
2018 · C. Madsen, M. R. Clausen, et al. · Blood Advances · 13
PDF
Effect of an acute oral ibuprofen intake on urinary aquaporin-2 excretion in healthy humans
2001 · R. S. Pedersen, H. Bentzen, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 12
SOX11 as a minimal residual disease marker for Mantle cell lymphoma
2014 · Anita Tranberg Simonsen, Camilla Darum Sørensen, et al. · Leukemia Research · 11
90y-Ibritumumab Tiuxetan (Zevalin ®)-BEAM/C with Autologous Stem Cell Support as Frontline Therapy for Advanced Mantle Cell Lymphoma. – Preliminary Results From the Third Nordic MCL Phase II Study (MCL3).
2009 · Arne Kolstad, Anna Laurell, et al. · Blood · 11
The Combination of Pixantrone, Etoposide, Bendamustine and, in CD20+ Tumors, Rituximab (PREBEN) Shows Promising Feasibility/Efficacy in Heavily Pre-Treated Aggressive Lymphomas of B- and T-Cell Phenotype - Results of the Pre-Trial Experience Leading to a Nordic Phase 1/2 Study (the PREBEN Trial)
2016 · Michael Roost Clausen, Sirpa Leppa, et al. · Blood · 10
SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?
2015 · Anita T. Simonsen, Marie Schou, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 10
Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1–3a follicular lymphoma
2017 · Rie S. Bech, Kasper L. Nielsen, et al. · British Journal of Haematology · 8
PDF
Works count: 47
Citation count: 1,246
H-index: 17
I10-index: 24
Year
Topic
Type